share_log
Reuters ·  May 6 08:02
Vyne Therapeutics Inc - Plans to Initiate Phase 1B Trials, With Top Line Results Anticipated in Second Half of 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment